These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2562414)

  • 1. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists].
    Andresen M; Arrese M; Dougnac A; Godoy J; Prat G; Chianale J
    Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy.
    Jones EA; Skolnick P
    Prog Liver Dis; 1990; 9():345-70. PubMed ID: 2156301
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of flumazenil in hepatic encephalopathy.
    Grimm G; Katzenschlager R; Holzner F; Ferenci P; Schneeweiss B; Laggner A; Lenz K; Druml W; Madl C
    Eur J Anaesthesiol Suppl; 1988; 2():147-9. PubMed ID: 2842131
    [No Abstract]   [Full Text] [Related]  

  • 6. [Flumazenil, hepatic encephalopathy and benzodiazepines].
    Sacristán JA; Soto J; Francis D; Sánchez R
    Med Clin (Barc); 1991 Mar; 96(8):317. PubMed ID: 1645830
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.
    Basile AS; Jones EA; Skolnick P
    Pharmacol Rev; 1991 Mar; 43(1):27-71. PubMed ID: 1674609
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine receptors and hepatic encephalopathy.
    Butterworth RF; Pomier Layrargues G
    Hepatology; 1990 Mar; 11(3):499-501. PubMed ID: 2155867
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R; Gyr K
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
    Pidoux B; Zylberberg P; Valla D; Opolon P
    Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist].
    Janicki P; Rewerski W
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of hepatic encephalopathy: studies in autopsied brain tissue from hepatic coma patients.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():131-6. PubMed ID: 19256152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.